A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma.

The inhalation of cyclosporin (Cs)A to the lung is limited by its hydrophobic properties. In order to improve the poor solubility of CsA, cyclodextrin (CD) was evaluated for its suitability for dry powder inhaler formation, and the benefit of an inhaled CsA/CD complex in vivo was demonstrated. The solubilising effect of CDs on CsA was measured by high-performance liquid chromatography. Ciliostatic activity and haemolysis were determined to assess some safety profiles of CDs. The efficacy of an inhaled CsA/CD complex was evaluated by eosinophil infiltration into the bronchoalveolar lavage fluid in actively sensitised mice. CDs markedly improved the poor solubility of CsA. The ciliostatic and haemolytic activities of maltosyl-alpha-CD were the weakest of all the tested CDs. CsA inhaled alone showed inhibitory effects on allergen-induced eosinophilia. Inhalation of the complex of CsA with maltosyl-alpha-CD, where the dose of CsA was approximately nine-times less than that of CsA inhaled alone, also inhibited eosinophil accumulation significantly, with a longer duration of action in comparison with the response to CsA alone. Thus the effective dose of cyclosporin A could be reduced by formation of a complex with maltosyl-alpha-cyclodextrin, and a wider therapeutic safety margin by inhalation of cyclosporin A as a complex with maltosyl-alpha-cyclodextrin could be expected.

A case simultaneously presenting with a rare portal collateral pathway and left gastric venous anomaly.

We had the opportunity to dissect an autopsy case who had developed a rare portal collateral pathway due to increased portal pressure resulting from liver cirrhosis and simultaneous abnormal left gastric venous distribution. The portal collateral pathway consisted of a well-developed communicating branch located between the left renal vein and the left gastric vein. The left gastric vein did not merge into the portal vein, but directly entered the liver after bifurcating near the hepatic hilum. One branch had an anastomosis to the left branch of portal vein in the liver and the other distributed in the hepatic quadrate lobe. We considered this aberrant left gastric vein to be a congenital residue of the embryological left portal vein. The present case is the third Japanese case to have been described minutely in the literature, following the two cases reported by Miyaki et al. (1987). Persistence of the umbilical vein and the absence of the celiac trunk were also observed.

SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats.

We have clarified the effects of SDZ ENA 713 (ENA), a new phenyl-carbamate derivative, on the spatial learning impairment and neurochemical indices of central cholinergic neurons in rats. Basal forebrain (BF) lesioning with ibotenic acid markedly impaired acquisition ability in the water maze task without changing swimming rates and decreased choline acetyltransferase (ChAT) activity in the frontal cortex of rats. ENA (0.1, 0.2 mg/kg, p.o.) significantly ameliorated the impairment in acquisition ability in a dose-dependent manner. At 0.2 mg/kg, ENA prevented the reduction in ChAT activity. In normal rats, ENA (1 mg/kg, p.o.) increased extracellular ACh concentration of the prefrontal cortex. On the other hand, tissue concentrations of norepinephrine, serotonin, dopamine and their metabolites were not changed in the frontal cortex, hippocampus and striatum of normal rats. These results suggest that ENA ameliorates spatial learning disability by not only facilitating the cholinergic transmission, but normalizing impaired ChAT activity in the learning-impaired rat model.

Methods of detection of lymphatics and their changes with oestrous cycle.

It is difficult to detect lymphatics, and it is extremely risky to identify a lymphatic by only one method. We are attempting accurate identification of a lymphatic by gradually narrowing the field of division by the use of four methods: (1) puncture injection of dye fluid; (2) arterial injection of silver nitrate solution and indian ink; (3) staining of semi- ultrathin sections with toluidine blue, and (4) confirmation by electron microscopy. Observation by these methods of the endometria of the human uterus and of rats in different stages of the respective oestrous cycles has revealed that the lymphatics change with the oestrous cycle. Interestingly, the changes are not only in the thickness but also in the number of lymphatics. Lymphatics have further been found not evenly distributed in organs but concentrated in certain areas.